Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net loss	$ (805,118)	$ (749,374)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization	72,358	24,011
Loss on disposal of property and equipment	232	1,525
Change in fair value of distribution liability for tax sharing agreement	(10,500)	0
Reduction of right-of-use assets from operating leases	22,254	16,571
Stock-based compensation expense, including cash settled	778,592	764,592
Amortization of deferred contract acquisition costs	51,628	35,977
Deferred income taxes	(17,086)	(5,544)
Changes in assets and liabilities:
Accounts receivable, net	135,453	37,261
Prepaid expenses and other current assets	(5,558)	(5,043)
Deferred contract acquisitions costs	(84,547)	(54,986)
Other assets	(1,203)	(13,104)
Lease liabilities	(17,250)	(10,369)
Accounts payable	(16,858)	14,875
Accrued liabilities	(39,124)	(8,232)
Deferred revenue	(61,366)	18,837
Other liabilities	(3,152)	(985)
Settlement of stock-based payments liabilities	(4,749)	(76,875)
Net cash flows used in operating activities	(5,994)	(10,863)
Cash flows from investing activities
Purchases of property and equipment	(36,203)	(29,711)
Cash paid for business combination, net of cash acquired	0	(25,000)
Net cash flows used in investing activities	(36,203)	(54,711)
Cash flows from financing activities
Proceeds from capital contributions from SAP	0	115,000
Proceeds from issuance of class A common stock, net of underwriting discounts and commissions	0	2,244,322
Payment of costs related to issuance of class A common stock	0	(3,081)
Repayment of promissory note	0	(1,892,280)
Payments for taxes related to net share settlement of equity awards	(270,909)	(27,800)
Issuance of class A common stock through Employee Stock Purchase Plan	32,521	16,586
Proceeds from exercise of stock options	1,470	0
Net cash flows (used in) provided by financing activities	(236,918)	452,747
Effect of changes in exchange rates on cash and cash equivalents	(3,672)	(1,118)
Net (decrease) increase in cash and cash equivalents	(282,787)	386,055
Cash and cash equivalents, beginning of period	1,014,511	203,891
Cash and cash equivalents, end of period	731,724	589,946
Supplemental cash flow disclosures
Cash paid for income taxes	36,226	7,848
Cash paid for operating leases, net of incentives received	18,610	10,008
Modification of cash-settled stock-based compensation awards into equity-settled awards	0	206,669
Non-cash investing and financing activities
Capital expenditures incurred but not yet paid	1,944	208
Right-of-use assets obtained in exchange for lease obligations	17,508	1,374
Note payable issued for dividend declared	0	500,000
Expiration of contingency associated with Class A common stock option exercised	$ 0	$ 120,000